Mani, Inc. Provides Earnings Guidance for the Fiscal Year 2022
October 12, 2021
Share
Mani, Inc. provided earnings guidance for the fiscal year 2022. The full fiscal year net sales forecast is JPY 18.801 billion, a year-on-year increase of JPY 1.61 billion. Operating income will increase from JPY 5.348 billion to JPY 5.892 billion, a year-on-year increase of JPY 544 million. Operating income is expected to increase by 10.2%.
Mani Inc is a Japan-based company mainly engaged in the manufacture and sale of medical equipment. The Company operates through three business segments. The Surgical-related Product segment is engaged in the provision of surgical suture needles and threads, as well as ophthalmic knives, born saws, blood vessel knives and other surgical equipment. The Eyeless Needle-related Product segment is engaged in the provision of eyeless surgical suture needles. The Dental-related Product segment is engaged in the manufacture and sale of dental root canal treatment equipment, such as reamers, files, broaches and cleansers; grinding and abrasive agents, such as carborundum points and silicone points; rotating dental treatment equipment, such as diamond burs, carbide burs, stainless burs and others, as well as dental materials, dental stereomicroscopes, among others.